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Abstract Tissue transglutaminase is a multifunctional enzyme
which has been involved in the regulation of cell growth,
differentiation, and apoptosis. Recently, nuclear localization of
tTG has been reported indicating the potential of active nuclear
transport. In this study we use the yeast two-hybrid assay and co-
immunoprecipitation to show that tTG interacts with the nuclear
transport protein importin-K3. Using electron microscopy we
demonstrate that nuclear expression of tTG in a non-small cell
lung cancer cell line is induced by retinoic acid (RA). These data
suggest that importin-K3 could mediate active nuclear transport
of tTG which may be important for the regulation of critical
cellular processes.
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1. Introduction
Tissue transglutaminase (tTG), or type II transglutaminase,
is an 80 kDa enzyme that has been implicated in the regula-
tion of cell growth [1,2], di¡erentiation [3,4], and apoptosis
[5,6]. In keeping with multiple physiological roles for tTG are
the numerous ¢ndings that expound its importance in tumor
growth and progression [7,8] and in the pathology of several
neurodegenerative diseases characterized with the expansion
of CAG (glutamine) repeats, such as Huntington’s disease
[9]. tTG is a member of a family of Ca2-dependent enzymes
that catalyze protein cross-linking reactions by creating O-
(Q-glutamyl)lysine bonds between the Q-carboxyl group of a
glutamine residue in one polypeptide chain and the O-amino
group of a lysine residue in a second polypeptide chain [10].
tTG possesses an additional feature that makes it unique
among other transglutaminases, namely, the ability to catalyze
GTP hydrolysis enabling it to participate in signal transduc-
tion by functioning as an K-subunit of a Gh-protein [11,12].
The G-protein activity of tTG has been shown to be critical
for its role in cell cycle progression [13]. It is yet unknown
which function of tTG, transglutaminase, G-protein, or both,
is responsible for its roles in cell growth, apoptosis and di¡er-
entiation, nor are the mechanisms regulating these functions
completely understood.
tTG has been localized mainly in the cytosol, however, a
detectable tTG expression, both as a cross-linking enzyme and
a G-protein, has been reported in the nucleus [14,15]. Two
nuclear substrates of the transglutaminase activity of tTG,
histones [16] and retinoblastoma protein (Rb) [17], have
been identi¢ed so far. Modi¢cation of both substrates by
polyamination or cross-linking may be relevant to the role
of tTG in cell cycle progression and apoptosis. Direct targets
of the G-protein activity of nuclear tTG are unknown. The
mechanisms of nuclear translocation of tTG have not been yet
demonstrated. We show here that the nuclear transport pro-
tein, importin-K3, is a speci¢c cellular binding partner for
tTG, thus establishing a molecular mechanism of active nu-
clear transport of tTG.
2. Materials and methods
2.1. Yeast two-hybrid assay
The Matchmaker II two-hybrid system (Clontech) was used to
screen a human liver cDNA library cloned into GAL4 activation
domain (AD) of pACT2 plasmid (Clontech). The bait construct was
created by subcloning the full length tTG gene into the GAL4 DNA-
binding domain (DNA-BD) of pAS2-1 plasmid by ligating the Hin-
dIII-EcoRI fragment from pIND (Invitrogen)-tTG cDNA into the
NdeI-EcoRI digested pAS2-1. The screening was performed according
to the manufacturer’s protocol. Sequencing of the isolated cDNA was
performed using the ABI Prizm Automated Sequencer (Model 377).
We utilized two primers, AGTTGAAGTGAACTTGCGG and CA-
GATTACGCTAGCTTGGG. The BLAST search algorithm was em-
ployed for sequence comparisons.
2.2. In vitro translation and protein-binding assay
Importin-K3 partial cDNA was excised from the pACT2 plasmid
and subcloned downstream from the T7 RNA polymerase promoter
in a PCR3-Uni plasmid (Invitrogen) by ligating the SmaI-XhoI frag-
ment from PACT2-importin-K3 cDNA. 35S-labeled importin-K3 was
synthesized in the TNT coupled reticulocyte transcription/translation
system (Promega) according to the manufacturer’s protocol.
In vitro translated 35S-labeled importin-K3 was incubated with or
without 3.5 Wg of puri¢ed guinea pig liver tTG (Sigma) in binding
bu¡er (20 mM HEPES pH 7.9, 20% glycerol, 0.5 mM EDTA, 60 mM
KCl, 6 mM MgCl2, 0.1% NP-40) for 60 min at 30‡C. Mixtures were
immunoprecipitated with polyclonal goat anti-guinea pig tTG anti-
body (Upstate Biotechnology), fractionated on SDS-PAGE, and
35S-labeled band was detected by autoradiography.
2.3. Cell culture
The non-small cell lung cancer (NSCLC) cell line, NCI-H596, was
grown in RPMI-1640 media (GIBCO BRL) supplemented with 10%
fetal bovine serum (FBS; GIBCO BRL) at 37‡C and 5% CO2. Where
indicated, 1035 M all-trans retinoic acid (RA; Sigma Chemical Co.)
was added in serum-free medium. RA was initially dissolved in
DMSO to a concentration of 1031 M and subsequently diluted in
RPMI medium without FBS to a ¢nal concentration of 1035 M.
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2.4. Immunoprecipitation and Western blot analysis
NCI-H596 cells were lysed by the addition of RIPA immunopre-
cipitation bu¡er (10 mM HEPES pH 7.5, 50 mM KCl, 2.5 mM
MgCl2, 1% Triton X-100, 1.5 mM EDTA, 0.1 mM Na3V04, 1 mM
phenylmethylsulfonyl £uoride, 10 Wg/ml aprotinin, and 10 Wg/ml leu-
peptin). tTG was immunoprecipitated for 1 h at 4‡C using polyclonal
goat anti-guinea pig tTG antibody (Upstate Biotechnology) or mono-
clonal antibody Cub 7401, speci¢c for tTG (gift from Dr. P. Birck-
bichler, Oklahoma Medical Research Foundation, Oklahoma City,
OK, USA) immobilized on Protein A/G agarose beads (Calbiochem).
Importin-K3 was immunoprecipitated with speci¢c polyclonal rabbit
antibody (generous gift of Dr. E. Hartmann, Max-Delbruºck-Centrum,
Berlin, Germany). Immunoprecipitated proteins were subjected to
Western blot analysis with anti-importin-K3 for tTG immunoprecipi-
tates and anti-tTG for importin immunoprecipitates. The proteins
were visualized using enhanced chemiluminescence (ECL) system
(Amersham).
2.5. Electron microscopy
Con£uent NCI-H596 cells were treated with or without 1035 M all-
trans retinoic acid (RA) for 0, 6 and 24 h. Cells were ¢xed with
glutaraldehyde, embedded in LRWhite (London Resin Co.) and
tTG was immunolocalized with monoclonal antibody Cub 7401 or,
as a negative control, with monoclonal antibody BC.1 speci¢c for
keratinocyte transglutaminase (kTG) (gift from Dr. S. Thacher, Al-
lergan, Irvine, CA, USA) followed by staining with anti-mouse IgG-
conjugated immunogold 10 nm particles. Electron microscopy was
performed using Philips SM10 electron microscope.
2.6. Immunohistochemistry
NCI-H596 cells were trypsinized and cytospins prepared. Cells were
permeabilized with methanol and saponin. tTG was immunolocalized
using monoclonal Cub 7401 antibody (1:20) for 1 h on ice, followed
by incubation with FITC-conjugated anti-mouse IgG (1:100, Vector)
for 2 h. Importin-K3 was immunolocalized using rabbit polyclonal
antibody (1:20) for 1 h on ice, followed by incubation with TRITC-
conjugated anti-rabbit IgG (1:100; Vector). Images were visualized
and superimposed using the Axoplan 2 (Zeiss) confocal £uorescent
microscope and QED (QED, Inc.) image analysis system.
3. Results and discussion
3.1. Identi¢cation of importin-K3 as a tTG-binding partner
using the yeast two-hybrid assay
To fully characterize the role of tTG in cellular processes it
is necessary to identify its intracellular targets. So far the tTG
targets were identi¢ed as the substrates of its transamidase
activity [16,17]. To detect other possible targets of tTG we
used the yeast two-hybrid assay which has been shown to
be e¡ective in detection of weak and transient protein-protein
interactions. We performed a two-hybrid screen with human
tTG cDNA fused to the GAL4 DNA-binding domain in the
pAS2-1 plasmid. For the two-hybrid screen, the recombinant
plasmids were co-transformed into a reporter yeast strain
Y190, which possesses the HIS3 and lacZ genes under control
of a GAL4 responsive element. Co-transformants were plated
on yeast drop-out media lacking leucine, tryptophan and his-
tidine to assay for activation of the HIS3 reporter gene. This
allowed for a positive growth selection of clones that were
transformed by the two interacting hybrid constructs. Positive
L-Galactosidase staining of the clones allowed further con¢r-
mation of the interaction.
Screening of the human liver cDNA library identi¢ed a
number of interacting clones. The speci¢city of interaction
with tTG was con¢rmed by bait plasmid loss and by the
absence of transactivation with non-speci¢c baits. Positive
clones were mated with clones of the Y187 yeast strain con-
taining the following non-speci¢c DNA-BD constructs: (1)
non-recombinant pAS2-1, (2) recombinant pAS2-1 encoding
for bait fusion, and (3) an unrelated fusion (the control plas-
mid pLAM 5P-1, Clontech). Diploids from the mating were
screened for L-Galactosidase expression. Positive clones that
speci¢cally interacted only with recombinant pAS2-1/tTG fu-
sion plasmid, but not with three other plasmids, were isolated.
The sequences of the cDNA from these clones were com-
pared with the nucleotide sequences of known proteins using
the BLASTN search algorithm. Nucleotide sequences of the
two positive clones (5-3 and 6-1) obtained from two separate
screenings demonstrated remarkable homology to nucleotide
and amino acid sequences of human importin-K3 (Qip-1) sub-
family proteins, importin-K3 and importin-K4, with amino
acid sequence identity of 100 and 93% respectively
(P = 3e398) by BLASTX. The region of homology spans
152^332 amino acids, which encompass arms 2 to 6 of eight
importin-K3 ‘armadillo’ repeats that are responsible for direct
binding of NLS [18]. Importin-K proteins belong to three
subfamilies, of which importin-K3 and importin-K4 constitute
the importin-K3/Qip-1-like subfamily [19]. Amino acid se-
quence identity of clones 5-3 and 6-1 with other proteins of
the importin-K family, importin-K1 and K2, was 48 and 53%,
respectively.
Analysis of the primary sequence of tTG suggested the
presence of a putative bipartite NLS with high homology to
the NLS of the NS1 non-structural protein of in£uenza virus
[20]. The ¢rst site (DILRR) is located at position 259^263 and
bears 80% homology to the NLS of the NS1 non-structural
protein of in£uenza virus [20], and the second (PKQKRK) is
located at position 597^602, and is identical to the second
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Fig. 1. Identi¢cation of putative NLS-like sequences in tTG. NLS-
like amino acid sequences were identi¢ed in tTG using the PROWL
search algorithm. Residues 597^602 (bold) are 100% similar to the
203^237 PKQKRK NLS sequence of in£uenza virus NS1 protein.
Residues 259^263 (bold) are 80% similar to the 34^38 DRLRR NS1
sequence.
Fig. 2. Binding of in vitro translated [35S]importin-K3 to puri¢ed
tTG. Position of MW standard (in kDa) is at right. In vitro trans-
lated [35S]methionine-labeled importin-K3 (polypeptide derived from
the two-hybrid construct) was mixed with puri¢ed guinea pig liver
tTG, which was then immunoprecipitated with polyclonal goat anti-
tTG antibody (lane 2). Non-speci¢c binding of importin-K3 to irrel-
evant goat antibody/Protein A agarose was assessed in the absence
of tTG (lane 1).
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NLS of the same viral protein (Fig. 1). Further experiments
are underway to con¢rm the functional signi¢cance of bipar-
tite NLS on tTG.
3.2. In vitro and in vivo interaction of importin-K3 with tTG
To con¢rm the importin-K3/tTG binding in vitro we have
demonstrated that in vitro translated [35S]methionine-labeled
importin-K3 was able to bind to human tTG immobilized on
Protein A/G agarose. No binding was observed when irrele-
vant antibody was used as a control for speci¢city (Fig. 2).
To determine whether importin-K3 interacted with tTG in
live mammalian cells, we used human non-small cell lung
cancer cell line, NCI-H596 with high expression of tTG [21].
We performed dual immunohistochemical staining of NCI-
H596 cells with anti-tTG and anti-importin-K3 antibodies
(Fig. 3). tTG was localized predominantly in the cytosolic
fraction with lower but detectable staining in the nuclei,
whereas importin-K3 was equally expressed in cytosolic and
nuclear regions. The uniform pattern of intracellular distribu-
tion of importin-K3 agrees with other published observations
and is due to the rapid shuttling of importin-3K between the
nucleus and the cytoplasm [22]. Co-localization of tTG and
importin-K3 could be detected in the cytosol indicating the
possible physiological association of the two molecules in
vivo. Such co-localization pattern also agrees with the known
mechanisms of importin-mediated nuclear transport, whereby
importin-K molecule remains bound to a transported protein
only in the cytosol and rapidly dissociates from it after cross-
ing the nuclear membrane [19,23].
To further con¢rm the in vivo association of tTG with
importin-K3, we performed co-immunoprecipitation of the
two proteins from NCI-H596 cell extracts. When importin-
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Fig. 3. Immuno£uorescent images showing intracellular distribution of tTG and importin-K3 in NCI-H596 cells. NCI-H596 cells were stained
with speci¢c polyclonal goat anti-tTG antibody (A, green) followed by staining with speci¢c polyclonal rabbit anti-importin-K3 antibody (B,
red). Superimposition of the images (C, yellow) demonstrates the co-localization of tTG and importin-K3 in the cytoplasm of NCI-H596 cells.
For negative control cells were double-stained with irrelevant isotype matched antibodies (D for superimposed image).
Fig. 4. Co-immunoprecipitation of tTG with antibody against im-
portin-K3 in cultured NCI-H596 cells. NCI-H596 cells were treated
with 1035 M RA for 0^6 h. Importin-K3 was immunoprecipitated
from the cytosolic fraction using polyclonal rabbit anti-importin-K3
antibody, and tTG (A) or importin-K3 (B) were detected in immu-
noprecipitates by Western blots as described in Section 2. tTG was
detected in cytosolic extracts of RA-treated NCI-H596 cells (C). Im-
munoprecipitation with irrelevant IgG, negative control (lane 1); 0,
3 and 6 h of incubation with RA (lanes 2, 3 and 4); total cytosolic
tTG, positive control (lane 5). Band densities were determined by
scanning densitometry and normalized to control.
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K3 was immunoprecipitated and immunoblotted with anti-
tTG antibody, the positive staining of an 85 kDa band was
observed (Fig. 4A). However, we were unable to detect im-
portin-K3 signal when tTG was precipitated using the anti-
tTG goat polyclonal antibody or Cub 7401 monoclonal anti-
body, followed by immunodetection with anti-importin-K3
antibody (data not shown). Since en route to the nucleus
tTG may form a complex with importin-K and -L, it is possi-
ble that in such a complex the anti-tTG antibody recognition
site is not exposed. Another explanation is that tTG:importin
stoichiometry in cells is not favorable for bringing down de-
tectable amounts of importin-K3 when tTG is immunopreci-
pitated.
3.3. Nuclear expression of tTG in NCI-H596 cells by electron
microscopy
Nuclear expression and activity of tTG both as a G-protein
and transamidase have been recently established [14,15]. We
examined nuclear localization of tTG in NCI-H596 cells
stimulated with all-trans retinoic acid (RA), which is known
to upregulate tTG and induce apoptosis in many cell types
including NSCLC [24,25]. To determine if tTG is localized to
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Fig. 5. Electron microscopic detection of tTG in NCI-H596 cells using immunogold staining. A: untreated cell; B: RA-treated cell. N, nucleus;
C, cytosol; arrow indicates a gold particle; bar indicates 1 Wm. At least 10 cells were examined in each group. No nuclear staining was ob-
served when monoclonal antibody against keratinocyte TG (BC.1) was used as a negative control (not shown).
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the nucleus in NCI-H596 cells we immunodetected intracellu-
lar tTG by electron microscopy using Cub 7401 monoclonal
antibody and immunogold-conjugated secondary antibody
(Fig. 5). By electron microscopy, nuclear tTG expression
was low in unstimulated NCI-H596 cells (0.3 þ 0.03 gold par-
ticles/Wm2), but was markedly upregulated after 24 h of incu-
bation with 1035 M RA (4.5 þ 1.29 gold particles/Wm2).
Although by 24 h RA upregulates protein expression of cyto-
solic tTG in NCI-H596 [25] this alone can not explain the
increased expression of nuclear tTG since the high molecular
weight of this protein, 80 kDa, precludes the passive di¡usion
of tTG through the nuclear membrane. In fact, upregulation
of nuclear tTG by RA in NCI-H596 cells was preceded by a
slight (1.4-fold by scanning densitometry) but statistically sig-
ni¢cant (P9 0.01) increase in tTG/importin-K3 co-immuno-
precipitation after 6 h of incubation (Fig. 4A) implicating
active nuclear transport in RA-challenged NSCLC cells. RA
did not alter the expression of importin-K3 or cytosolic tTG
by 6 h of incubation (Fig. 4B, C).
Our data demonstrate that a nuclear transport protein, im-
portin-K3, is an intracellular tTG-binding counterpart.
Although the possibility that importin-K3 is a mere target of
tTG transamidase activity cannot be excluded, our data and
previous observations are consistent with importin-K3 being
involved in the active transport of tTG into the nucleus. Dis-
covery of the tTG/importin interaction was unexpected, but
not surprising. Several pieces of evidence, including the data
presented in this report, indicate the nuclear expression of
tTG [14,15]. Considering the high molecular weight of this
protein, 80 kDa, active nuclear transport is the only means
to translocate this molecule through the nuclear membrane.
The role of nuclear tTG has not been addressed so far. This
study indicates that RA, which has been shown to induce
apoptosis in NSCLC cells speci¢cally upregulates nuclear
tTG expression. An intriguing possibility is that nuclear
tTG activity is responsible for the known roles of tTG in
cell cycle progression and apoptosis. Identi¢cation of nuclear
histones and Rb protein as the tTG substrates suggested the
potential mechanisms of such roles.
In conclusion, results from this study suggest that tTG may
be actively transported into the nucleus via binding to an
importin-K3/Qip-1 family protein. Experiments are in progress
to de¢ne the NLS within tTG by site-directed mutagenesis.
Further studies are underway to con¢rm the functional rele-
vance of importin-K binding and nuclear transport of tTG in
cellular processes.
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